Dapivirine Vaginal Ring: Phase III data

Top-line data from the double-blind Phase III ASPIRE trial in 2,629 HIV-negative women ages 18-45 in Malawi, South Africa, Uganda and Zimbabwe showed that a once-monthly vaginal ring containing 25 mg ...